These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35053513)

  • 1. Exploring Response to Immunotherapy in Non-Small Cell Lung Cancer Using Delta-Radiomics.
    Barabino E; Rossi G; Pamparino S; Fiannacca M; Caprioli S; Fedeli A; Zullo L; Vagge S; Cittadini G; Genova C
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of delta-radiomic features for prognosis of advanced non-small cell lung cancer patients undergoing immune checkpoint inhibitor therapy.
    Han X; Wang Y; Jia X; Zheng Y; Ding C; Zhang X; Zhang K; Cao Y; Li Y; Xia L; Zheng C; Huang J; Shi H
    Transl Lung Cancer Res; 2024 Jun; 13(6):1247-1263. PubMed ID: 38973966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of computed tomography imaging-based radiomics and clinicopathological characteristics for predicting the clinical benefits of immune checkpoint inhibitors in lung cancer.
    Yang B; Zhou L; Zhong J; Lv T; Li A; Ma L; Zhong J; Yin S; Huang L; Zhou C; Li X; Ge YQ; Tao X; Zhang L; Son Y; Lu G
    Respir Res; 2021 Jun; 22(1):189. PubMed ID: 34183009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delta radiomics model for the prediction of progression-free survival time in advanced non-small-cell lung cancer patients after immunotherapy.
    Xie D; Xu F; Zhu W; Pu C; Huang S; Lou K; Wu Y; Huang D; He C; Hu H
    Front Oncol; 2022; 12():990608. PubMed ID: 36276082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Response to Immune Checkpoint Inhibitors Using a Radiomics, Lesion-Level Approach.
    Song C; Park H; Lee HY; Lee S; Ahn JH; Lee SH
    Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiomics and Delta-Radiomics Signatures to Predict Response and Survival in Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.
    Cousin F; Louis T; Dheur S; Aboubakar F; Ghaye B; Occhipinti M; Vos W; Bottari F; Paulus A; Sibille A; Vaillant F; Duysinx B; Guiot J; Hustinx R
    Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feature selection methodology for longitudinal cone-beam CT radiomics.
    van Timmeren JE; Leijenaar RTH; van Elmpt W; Reymen B; Lambin P
    Acta Oncol; 2017 Nov; 56(11):1537-1543. PubMed ID: 28826307
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Polverari G; Ceci F; Bertaglia V; Reale ML; Rampado O; Gallio E; Passera R; Liberini V; Scapoli P; Arena V; Racca M; Veltri A; Novello S; Deandreis D
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32380754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel clinical and radiomic predictors of rapid disease progression phenotypes among lung cancer patients treated with immunotherapy: An early report.
    Tunali I; Gray JE; Qi J; Abdalah M; Jeong DK; Guvenis A; Gillies RJ; Schabath MB
    Lung Cancer; 2019 Mar; 129():75-79. PubMed ID: 30797495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiomics to predict outcomes and abscopal response of patients with cancer treated with immunotherapy combined with radiotherapy using a validated signature of CD8 cells.
    Sun R; Sundahl N; Hecht M; Putz F; Lancia A; Rouyar A; Milic M; Carré A; Battistella E; Alvarez Andres E; Niyoteka S; Romano E; Louvel G; Durand-Labrunie J; Bockel S; Bahleda R; Robert C; Boutros C; Vakalopoulou M; Paragios N; Frey B; Soria JC; Massard C; Ferté C; Fietkau R; Ost P; Gaipl U; Deutsch E
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33188037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI-based delta-radiomics predicts pathologic complete response in high-grade soft-tissue sarcoma patients treated with neoadjuvant therapy.
    Peeken JC; Asadpour R; Specht K; Chen EY; Klymenko O; Akinkuoroye V; Hippe DS; Spraker MB; Schaub SK; Dapper H; Knebel C; Mayr NA; Gersing AS; Woodruff HC; Lambin P; Nyflot MJ; Combs SE
    Radiother Oncol; 2021 Nov; 164():73-82. PubMed ID: 34506832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in Serial Imaging for Prognostic Stratification of Lung Cancer Patients Receiving Immunotherapy: A Systematic Review and Meta-Analysis.
    Chiu HY; Wang TW; Hsu MS; Chao HS; Liao CY; Lu CF; Wu YT; Chen YM
    Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiomics study for predicting the expression of PD-L1 in non-small cell lung cancer based on CT images and clinicopathologic features.
    Sun Z; Hu S; Ge Y; Wang J; Duan S; Song J; Hu C; Li Y
    J Xray Sci Technol; 2020; 28(3):449-459. PubMed ID: 32176676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive Radiomic Models for the Chemotherapy Response in Non-Small-Cell Lung Cancer based on Computerized-Tomography Images.
    Chang R; Qi S; Yue Y; Zhang X; Song J; Qian W
    Front Oncol; 2021; 11():646190. PubMed ID: 34307127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between CT based radiomics features and gene expression data in non-small cell lung cancer.
    Wang T; Gong J; Duan HH; Wang LJ; Ye XD; Nie SD
    J Xray Sci Technol; 2019; 27(5):773-803. PubMed ID: 31450540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal radiomics of cone-beam CT images from non-small cell lung cancer patients: Evaluation of the added prognostic value for overall survival and locoregional recurrence.
    van Timmeren JE; van Elmpt W; Leijenaar RTH; Reymen B; Monshouwer R; Bussink J; Paelinck L; Bogaert E; De Wagter C; Elhaseen E; Lievens Y; Hansen O; Brink C; Lambin P
    Radiother Oncol; 2019 Jul; 136():78-85. PubMed ID: 31015133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation Versus Immune Checkpoint Inhibitor Associated Pneumonitis: Distinct Radiologic Morphologies.
    Chen X; Sheikh K; Nakajima E; Lin CT; Lee J; Hu C; Hales RK; Forde PM; Naidoo J; Voong KR
    Oncologist; 2021 Oct; 26(10):e1822-e1832. PubMed ID: 34251728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of pre-therapy
    Zhang J; Zhao X; Zhao Y; Zhang J; Zhang Z; Wang J; Wang Y; Dai M; Han J
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1137-1146. PubMed ID: 31728587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review of radiomic biomarkers for predicting immune checkpoint inhibitor treatment outcomes.
    Zhang C; de A F Fonseca L; Shi Z; Zhu C; Dekker A; Bermejo I; Wee L
    Methods; 2021 Apr; 188():61-72. PubMed ID: 33271285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiating Peripherally-Located Small Cell Lung Cancer From Non-small Cell Lung Cancer Using a CT Radiomic Approach.
    Chen BT; Chen Z; Ye N; Mambetsariev I; Fricke J; Daniel E; Wang G; Wong CW; Rockne RC; Colen RR; Nasser MW; Batra SK; Holodny AI; Sampath S; Salgia R
    Front Oncol; 2020; 10():593. PubMed ID: 32391274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.